Successful management of Crohn's disease of the ileoanal pouch with infliximab

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 429-432

  Ricart, E ^a   Panaccione, R ^a   Loftus, E V ^a   Tremaine, W J ^a   Sandborn, W J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON CROHN DISEASE; COLON RESECTION; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HUMAN; ILEUM POUCH; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALAISE; MALE; MYALGIA; PRIORITY JOURNAL;

EID: 0032790465     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900429     Document Type: Article

References (13)

1. J.H. Pemberton K.A. Kelly R.W. Beart Jr R.R. Dozois B.G. Wolff D.M. Ilstrup Ileal pouch–anal anastomosis for chronic ulcerative colitis. Long-term results Ann Surg 206 1987 504 513
2. N.H. Hyman V.W. Fazio W.B. Tuckson I.C. Lavery Consequences of ileal–pouch anastomosis for Crohn's disease Dis Colon Rectum 34 1991 653 657
3. A.A. Deutsch R.S. Mcleod J. Cullen Z. Cohen Results of the pelvis-pouch procedure in patients with Crohn's disease Dis Colon Rectum 34 1991 475 477
4. S. Galandiuk N. Scott R. Dozois K. Kelly D. Ilstrup R. Beart B. Woff J. Pemberton S. Nivatvongs R. Devine Ileal pouch anastomosis Ann Surg 212 1990 446 454
5. W.A. Koltun D.J. Schoetz Jr P.L. Roberts J.J. Murray J.A. Coller M.C. Veidenheimer Indeterminate colitis predisposes to perineal complications after ileal pouch–anal anastomosis Dis Colon Rectum 34 1991 857 860
6. S. Wexner L. Jensen D. Rothenberber W. Wong S. Goldberg Long-term functional analysis of the ileoanal reservoir Dis Colon Rectum 32 1989 273 281
7. L.J. Brandt L.H. Bernstein S.J. Boley M.S. Frank Metronidazole therapy for perineal Crohn's disease: a follow-up study Gastroenterology 83 1982 383 387
8. B.J. Korelitz D.H. Present Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease Dig Dis Sci 30 1985 58 64
9. L.J. Egan W.J. Sandborn W.J. Tremaine Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine Am J Gastroenterol 93 1998 442 448
10. D.H. Present P. Rutgeerts S. Targan S.B. Hanauer L. Mayer R.A. van Hogezand D.K. Podolsky B.E. Sands T. Braakman K.L. Dewoody T.F. Schaible S.J.H. van Deventer Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1999 1398 1405
11. SR Targan SB Hanauer SJH Van Deventer L Mayer DH Present TAJ Braakman KL DeWoody TF Schaible P Rutgeerts the Crohn's disease cA2 Study Group A short-time study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn's disease N Engl J Med 337 1997 1029 1035
12. R.N. Maini F.C. Breeveld J.R. Kalden J.S. Smolen D. Davis J.D. Macfarlane C. Antoni B. Leed M.J. Elliot J.N. Woody T.F. Schaible M. Feldman Therapeutic efficacy of multiple intravenous infusions of anti–tumor necrosis factor monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid ar thritis Arthritis Rheum 41 1998 1552 1563
13. Remicade (infliximab). Prescribing Information. Physicians Desk Reference 1999 1999 Medical Economics Montvale, NJ